The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
Open accessAbstract
Natural as well as synthetic coumarins have recently drawn much attention due to its broad pharmacological activities. Many coumarins and their derivatives exert anti-coagulant, anti-tumor, anti-viral, anti-inflammatory and anti-oxidant effects, as well as anti-microbial and enzyme inhibition properties. The recognition of key structural features within coumarin family is crucial for the design and development of new analogues with improved activity and for the characterization of their mechanism of action and potential side effects. The different substituents in the coumarin nucleus strongly influence the biological activity of the resulting derivatives. Although some coumarins have been already characterized to evoke a particular biological activity, the challenge would be the design and synthesis of new derivatives with high specific activity for other pharmacological targets and define their mechanism of action to achieve new therapeutic drugs. The present review highlights the current progress in the development of coumarin scaffolds for drug discovery as novel anti-cancer agents. The major challenges about coumarins include the translation of current knowledge into new potential lead compounds and the repositioning of known compounds for the treatment of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Petersen, P., Godtfredsen, J., Boysen, G., Andersen, E., & Andersen, B. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91200-2 · Cited by 1,820
Natural and Synthetic Coumarin Derivatives with Anti-Inflammatory / Antioxidant Activities
Fylaktakidou, K., Hadjipavlou-Litina, D., Litinas, K., & Nicolaides, D. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043382710 · Cited by 970
Coumarins : biology, applications, and mode of action
O’Kennedy, R. J., & THORNES, R. D. (1997) · Medical Entomology and Zoology · Cited by 959
Hoult, J. R. S., & Payá, M. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02112-4 · Cited by 951
Laughton, M. J., Evans, P. J., Moroney, M. A., Hoult, J. R. S., & Halliwell, B. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90501-u · Cited by 598
The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds
Egan, D., O'kennedy, R., Moran, E., Cox, D., Prosser, E., & Thornes, R. D. (1990) · Drug Metabolism Reviews · doi:10.3109/03602539008991449 · Cited by 558
A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Musa, M., Cooperwood, J., & Khan, M. O. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242877 · Cited by 538
Levine, M. N., Hirsh, J., Gent, M., Turpie, A. G., Weitz, J., Ginsberg, J., Geerts, W., LeClerc, J., Neemeh, J., Powers, P., et al. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649783 · Cited by 353
Differentiation therapy of leukemia: 3 decades of development.
Nowak, D., Stewart, D., & Koeffler, H. P. (2009) · Blood · doi:10.1182/blood-2009-01-198911 · Cited by 348
Lewis, R. J., Singh, O. M., Smith, C. V., Skarzynski, T., Maxwell, A., Wonacott, A. J., & Wigley, D. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00483.x · Cited by 335
Cited by
Kostova, I., Bhatia, S., Grigorov, P., Balkansky, S., S. Parmar, V., K. Prasad, A., & Saso, L. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711803414395 · Cited by 435
Molecular interplay between cdk4 and p21 dictates G0/G1 cell cycle arrest in prostate cancer cells
Gulappa, T., Reddy, R. S., Suman, S., Nyakeriga, A. M., & Damodaran, C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.014 · Cited by 43
Metadata
- Authors
- Riveiro, M., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., & Davio, C.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-05-01
- Volume
- 17
- Issue
- 13
- Pages
- 1325-1338
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2128531001
- Cited by
- 448
- References
- 72
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives. https://app.cochat.ai/papers/10.2174/092986710790936284
- The paper
- Riveiro, M., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., & Davio, C. (2010). Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives. Current Medicinal Chemistry. https://doi.org/10.2174/092986710790936284
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.